Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Introduction Heart failure (HF) represents an important burden to the medical system attending to its high prevalence and high risk of hospital admissions by decompensations. Remote monitoring (RM) systems using invasive and non-invasive parameters were developed to anticipate clinical deterioration in patients with cardiac implantable electronic devices (CIEDs). Objective To characterize a cohort of patients with HF and CIEDs in an outermost region. We aimed to accessed data from monitoring device algorithms and to analyze the real impact in clinical decompensations, hospital admissions and all-cause mortality. Methods Retrospectively multicenter cohort study included 211 patients with HFrEF and CIEDs, between 2010 and 2020. This study population was divided into two specific groups: Group A including patients with RM data and Group B including patients who receive usual care at regular hospital consultations. RM technology applied used different parameters to access the risk of worsening HF and stablishing an alert threshold. Results Out of 211 patients enrolled, 75% were male and 44.8% were in NYHA functional class II at the time of device implantation. One-hundred and twenty (56.9%) received in-home monitoring system (89% Latitude® and 10.8% Carelink®), corresponding to the Group A. The remaining 91 patients (43.1%) were included in Group B. Forty-nine patients (40.8%) had transvenous implantable cardioverter defibrillator (ICD), 13 (10.8%) had a subcutaneous ICD, 54 (45%) a cardiac resynchronization therapy (CRT) defibrillator and 4 (3.3%) a CRT pacemaker. Group A patients did not have coronary artery disease (p 0.047) and were younger than patients in Group B (median age 66 years, IQR 55 – 73; median age 70 years, IQR 63 – 77). No other statistically differences in main comorbidities were detected between groups. The number of atrial fibrillation (AF) episodes and AF burden was higher in Group A during the follow-up (p 0.006) as well as non-sustained ventricular tachycardia episodes (p 0.016). However, no differences were accessed in emergency department (ED) admissions or heart failure hospitalizations (HFH) by decompensation for patients in group A who received alerts versus patients who not received (p 0.178 and p 0.748, respectively) nor between group A and B (p 0.921 and p 0.213, respectively). Patients in group A had a lower all-cause mortality rate (p < 0.001) and cardiovascular mortality (p 0.002), but no difference in life-threatening ventricular events occurred. Conclusion In our cohort of HF patients, remote monitoring allowed the premature detection and the correct quantification of arrhythmic events but did not reflect any difference in ED nor HFH by decompensation. Instead, RM system demonstrates ability to reduce global mortality when compared to conventional care. More data about the application of this system and the ideal tracking algorithms are necessary.

Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF

Evaluation Of The Degree Of Decongestion Among Patients Admitted With Acutely Decompensated Heart Failure Utilizing The Novel HEMOTAGTM Cardiopulmonary Assessment System

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

Noninvasive biometric monitoring technologies for patients with heart failure

Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events: Results From SCALE-HF 1

Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?

CardioMEMS™: a tool for remote hemodynamic monitoring of chronic heart failure patients

A Multimodal Approach to Congestion Assessment

Nurse led assessment of congestion in outpatient heart failure patients: remote dielectric sensing versus lung ultrasound comparison

Telemonitoring heart failure in a remote region: data from cardiac implantable electronic devices

Machine learning-based analysis of non-invasive measurements for predicting intracardiac pressures

Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

Multiparametric assessment of decongestion in patients admitted with acute heart failure: dynamic changes and correlation with natriuresis

Poor in-hospital congestion improvement in acute heart failure patients classified according to left ventricular ejection fraction: prognostic implications

Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial

Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG‐HF

Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment

Biomarkers of Hemodynamic Congestion in Heart Failure

Cardiovascular Implantable Electronic Devices Enabled Remote Heart Failure Monitoring; What We Have Learned and Where to Go Next